Member Info for Laura2022

6.2p

Must have been a buy ?

30th Sept will give more information

The Company's interim results for the six months ended 30 June 2025 will be released on 30 September 2025.

 

Ash and cash equivalents stood at £2.71 million at the end of August 2025, which, subject to a number of variables is currently expected to provide working capital into January 2026. This takes into account the impact of the IP Milestone grant timing and assumes no growth in revenue or other sources of income. In light of the reduced operating cashflow and the delay of the IP Milestone payment above, the Company is exploring a number of different avenues to extend its cash runway, including considering commercial options and opportunities for financing. As part of this process, the Company is intending to undertake a significant restructuring to ensure that its cost base better reflects the Company's current stage of commercial progress. The Company will update the market on any developments in due course.

GLR90

Looks more to be the tr1 seller from 2 weeks ago.

Will be near 130mln

More than enough if Newlands want to clear this Tr1

55,500,000

Here

Polarean Imaging plc (AIM: POLX), a commercial-stage medical imaging technology leader in functional Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received an order for a new Xenon MRI System from the National Institutes of Health ("NIH") Clinical Center in Bethesda, Maryland, USA. This is the world's largest hospital dedicated exclusively to clinical research, and this is the first system to be purchased directly from Polarean by the NIH.

Brilliant

Now

Almost 0.44p to sell on a 0 4p advertising

Now 0.45/47

25th Sept IMC will be chance to ask Q

Can sell 1.9mln 0 43p

Can pnly buy about 200-400k 0 45

Plenty of Fda news between now and Dec 2025 as outlined today amd in update pver summer

Also from Phillip

Yet can sell 1.8mln at 0 45

Managed just £1k at 0.4

Was already smashed down and priced in

Since appointing Dr. Alan Huang as Vice President in September 2024, our commercial efforts have generated a strong and robust pipeline of potential opportunities for sales. The Company has outstanding quotes to potential customers which it continues to pursue that could result in over US$21m of future sales, an increase of over 650% from this time last year. Our backlog, including orders delivered since 30 June 2025 and those currently in process, totals US$1.2m.

Thanks ralph

Yes Davey/Rivaldo etc

I would imagine there is a buyer too as we saw last RNS

Buys